Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

ACCELERON PHARMA INC (XLRN)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsDec-31-20Dec-31-19Dec-31-18Dec-31-17Dec-31-16Dec-31-15Dec-31-14Dec-31-13
   10-K10-K10-K10-K10-K10-K10-K10-K
Revenues   [+]92.574.014.013.527.818.114.657.2
            Revenue growth  25.0%428.9%3.8%-51.5%53.5%23.7%-74.4%275.2%
Cost of goods sold  0.00.00.00.00.00.05.00.0
Gross profit  92.574.014.013.527.818.19.657.2
            Gross margin  100.0%100.0%100.0%100.0%100.0%100.0%65.8%100.0%
Selling, general and administrative   [+]85.956.534.533.725.320.614.214.2
Research and development  173.9154.0103.989.768.658.450.936.1
Other operating expenses  -1.9-0.4  7.3-3.55.0 
EBITDA   [+]-161.6-132.1-120.7-107.2-71.7-56.2-59.37.9
            EBITDA margin  -174.6%-178.6%-862.5%-794.9%-258.3%-310.6%-405.6%13.7%
Depreciation and amortization  3.83.93.72.81.71.21.10.9
EBIT   [+]-165.4-136.1-124.4-110.0-73.4-57.4-60.57.0
            EBIT margin  -178.8%-183.9%-889.2%-815.8%-264.3%-317.1%-413.2%12.1%
Non-recurring items  1.90.4  -7.33.5-5.0 
Interest income, net   [+]2.910.75.62.61.90.5-0.8-2.1
Other income (expense), net   [+]-1.60.8-0.1-1.07.3-3.55.0-26.8
Pre-tax income  -166.0-124.9-118.9-108.4-57.0-63.9-51.3-21.9
Income taxes  0.0-0.10.00.00.00.00.00.0
            Tax rate   0.0%0.0%  0.0%0.0%0.0%
Net income  -166.0-124.9-118.9-108.5-57.0-63.9-51.3-39.0
            Net margin  -179.4%-168.7%-849.6%-804.5%-205.3%-353.1%-350.3%-68.2%
   
Basic EPS   [+]($2.92)($2.38)($2.59)($2.68)($1.52)($1.92)($1.63)($4.15)
Diluted EPS   [+]($2.92)($2.38)($2.59)($2.68)($1.52)($1.92)($1.63)($4.15)
   
Shares outstanding (basic)   [+]56.852.545.940.437.433.331.59.4
Shares outstanding (diluted)   [+]56.852.545.940.437.433.331.59.4
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy